Workflow
PRIME by MangoRx
icon
Search documents
Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model
Benzinga· 2026-02-20 14:59
Mangoceuticals, Inc. (NASDAQ:MGRX) shares are trading higher Friday after the company announced initial success for its newly launched all-inclusive injectable Testosterone Replacement Therapy treatment program.Mangoceuticals stock is among today’s top performers. What’s behind MGRX gains?Early Traction Validates $99 Subscription ModelThe company said month-over-month sales of its injectable TRT program increased 336% since launching in mid-December. MangoRx also reported a 54% reduction in customer acquisi ...
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Globenewswire· 2026-02-19 21:05
Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC) DALLAS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company” or “MangoRx”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that MangoRx has experienced initial success for its newly launched all-inclusive injectable Testosterone Replacement Therapy ...
Mangoceuticals(MGRX) - Prospectus(update)
2026-01-23 22:07
As filed with the Securities and Exchange Commission on January 23, 2026 Registration No. 333-292711 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to UNDER THE SECURITIES ACT OF 1933 Mangoceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) FORM S-1 REGISTRATION STATEMENT 17130 N. Dallas Parkway, Suite 240 Dallas, Texas 75248 (214 ...
Mangoceuticals(MGRX) - Prospectus
2026-01-13 22:30
As filed with the Securities and Exchange Commission on January 13, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Mangoceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) Texas 8099 87-3841292 (State or other jurisdiction of (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 17130 N. Dallas Parkway, Suite 240 Dallas, Texas 7524 ...